公开(公告)号：US20180222973A1

公开(公告)日：2018-08-09

申请号：US15879064

申请日：2016-07-27

Applicant: Novartis AG

Inventor： Marie-Louise Fjaellskog ,  John Scott Cameron ,  Zhu Cao ,  Daniela Cipolletta ,  kenzie Maclsaac

IPC: C07K16/24 ,  C07K16/28 ,  A61K39/395 ,  A61K45/06 ,  A61P35/00 ,  C07K16/30

Abstract: The present application n relates to a pharmaceutical composition comprising a PD-1 antibody and an M-CSF antibody. The combination can be administered independently or separately, in a quantity which is therapeutically effective for the treatment of cancer.

公开(公告)号：US11001628B2

公开(公告)日：2021-05-11

申请号：US15879064

申请日：2016-07-27

Applicant: Novartis AG

Inventor： Marie-Louise Fjaellskog ,  John Scott Cameron ,  Zhu Cao ,  Daniela Cipolletta ,  Kenzie MacIsaac

IPC: A61K39/395 ,  A61K39/00 ,  C07K16/24 ,  C07K16/28 ,  A61K45/06 ,  C07K16/30 ,  A61P35/00

Abstract: The present application n relates to a pharmaceutical composition comprising a PD-1 antibody and an M-CSF antibody. The combination can be administered independently or separately, in a quantity which is therapeutically effective for the treatment of cancer.